Status:
RECRUITING
Prognostic Value of Neurometabolic Networks in CRC (PVNM-CRC)
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Conditions:
Cancer
Brain Injury
Eligibility:
All Genders
18+ years
Brief Summary
Colorectal cancer (CRC), with annually increasing incidence and mortality worldwide, has become the second leading cause of cancer-related death. The development of CRC often follows the canonical nor...
Detailed Description
OBJECTIVE(S) \& HYPOTHESIS(ES) Objective: Evaluate area under curve (AUC) of BRIDGE in predicting overall survival (OS) for CRC patients. Compare the AUC of BRIDGE with clinical prediction models in p...
Eligibility Criteria
Inclusion
- Male/Female subjects with rectal cancer of at least 18 years of age will be enrolled in this trial.
Exclusion
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
213 Patients enrolled
Trial Details
Trial ID
NCT06930586
Start Date
March 1 2024
End Date
December 31 2027
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PET/CT
Henan, Henan, China, 450052